Salvia miltiorrhiza: An ancient Chinese herbal medicine as a source for anti-osteoporotic drugs

Journal of Ethnopharmacology

Volumn 155, Issue 3, 2014, Pages 1401-1416

  Guo, Yubo ^a   Li, Yu ^a   Xue, Liming ^b   Severino, Richele P ^b   Gao, Sihua ^a   Niu, Jianzhao ^a   Qin, Lu Ping ^c   Zhang, Dongwei ^a,b   Brömme, Dieter ^b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Anti resorptive activity; Danshen; Osteoporosis; Pro anabolic activity; Salvia miltiorrhiza

Indexed keywords

15,16 DIHYDROTANSHINONE I; AGENTS AFFECTING METABOLISM; CAFFEIC ACID; CATHEPSIN K; CRYPTOTANSHINONE; DITERPENOID; ISOCRYPTOTANSHINONE I; ISOCRYPTOTANSHINONE II; ISOTANSHINONE I; ISOTANSHINONE II; LITHOSPERMIC ACID; MASLINIC ACID; METHYLTANSHINONE; NEO TANSHINLACTONE; OLEANOLIC ACID; PLANT MEDICINAL PRODUCT; PROTOCATECHUALDEHYDE; PROTOCATECHUIC ACID; ROSMARINIC ACID; SALVIA MILTIORRHIZA EXTRACT; SALVIANOLIC ACID A; SALVIANOLIC ACID B; SALVIANOLIC ACID C; TANSHINDIOL C; TANSHINLACTONE; TANSHINOL; TANSHINONE I; TANSHINONE IIA; TANSHINONE IIB; UNCLASSIFIED DRUG; URSOLIC ACID; ANABOLIC AGENT; BONE DENSITY CONSERVATION AGENT; HERBACEOUS AGENT;

BIOSYNTHESIS; BONE DENSITY; BONE DEVELOPMENT; CHINA; CHINESE MEDICINE; DRUG EFFICACY; HUMAN; HYDROPHILICITY; IN VITRO STUDY; LIPOPHILICITY; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PHYTOCHEMISTRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SALVIA MILTIORRHIZA; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY;

ANABOLIC AGENTS; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CATHEPSIN K; DRUGS, CHINESE HERBAL; HUMANS; OSTEOPOROSIS; PHYTOCHEMICALS; SALVIA MILTIORRHIZA;

EID: 84907807760     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2014.07.058     Document Type: Review

References (129)

1. J. Banu Causes, consequences, and treatment of osteoporosis in men Drug Design, Development and Therapy 7 2013 849 860
2. G. Bhutani, and M.C. Gupta Emerging therapies for the treatment of osteoporosis Journal of Midlife Health 4 2013 147 152
3. Q. Bian, J.H. Huang, Z. Yang, Y. Ning, Y.J. Zhao, Y.J. Wang, and Z.Y. Shen [Effects of active ingredients in three kidney-tonifying Chinese herbal drugs on gene expression profile of bone marrow stromal cells from a rat model of corticosterone-induced osteoporosis] Zhong Xi Yi Jie He Xue Bao 9 2011 179 185
4. Q. Bian, S.F. Liu, J.H. Huang, Z. Yang, D.Z. Tang, Q. Zhou, Y. Ning, Y.J. Zhao, S. Lu, Z.Y. Shen, and Y.J. Wang Oleanolic acid exerts an osteoprotective effect in ovariectomy-induced osteoporotic rats and stimulates the osteoblastic differentiation of bone mesenchymal stem cells in vitro Menopause 19 2012 225 233
5. W.C. Black, and M.D. Percival The consequences of lysosomotropism on the design of selective cathepsin K inhibitors ChemBioChem 7 2006 1525 1535
6. S. Boonen, E. Rosenberg, F. Claessens, D. Vanderschueren, and S. Papapoulos Inhibition of cathepsin K for treatment of osteoporosis Current Osteoporosis Reports 10 2012 73 79
7. 2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution Biological Chemistry Hoppe Seyler 376 1995 379 384
8. D. Bromme, and F. Lecaille Cathepsin K inhibitors for osteoporosis and potential off-target effects Expert Opinion on Investigational Drugs 18 2009 585 600
9. D. Bromme Cystein cathepsins and the skeleton Clinical Reviews in Bone and Mineral Metabolism 9 2011 83 93
10. H.J. Chae, S.W. Chae, D.H. Yun, K.S. Keum, S.K. Yoo, and H.R. Kim Prevention of bone loss in ovariectomized rats: the effect of Salvia miltiorrhiza extracts Immunopharmacology & Immunotoxicology 26 2004 135 144
11. R.D. Chapurlat Odanacatib for the treatment of postmenopausal osteoporosis Expert Opinion on Pharmacotherapy 15 2014 97 102
12. J. Chen, M. Shao, Y. Du, H. Huang, B. Zhu, and Y. Lin Clinical observations on the effect of Gukang oral liquid on post-menopausal osteoporosis in 36 cases Journal of New Chinese Medicine 31 1999 22 23
13. X.W. Chen, K.B. Sneed, S.Y. Pan, C. Cao, J.R. Kanwar, H. Chew, and S.F. Zhou Herb-drug interactions and mechanistic and clinical considerations Current Drug Metabolism 13 2012 640 651
14. X. Chen, J. Guo, J. Bao, J. Lu, and Y. Wang The anticancer properties of Salvia Miltiorrhiza bunge (Danshen): a systematic review Medicinal Research Reviews 2013 ([Epub 2013 Oct 7])
15. T.O. Cheng Cardiovascular effects of Danshen International Journal of Cardiology 121 2007 9 22
16. H.T. Cheng, X.L. Li, L. X.R., Y.H. Li, L.Y. Wang, and M. Xue Simultaneous quantification of selected compounds from Salvia herbs by HPLC method and their application Food Chemistry 130 2012 1031 1035
17. C.F. Chien, Y.T. Wu, and T.H. Tsai Biological analysis of herbal medicines used for the treatment of liver diseases Biomedical Chromatography 25 2011 21 38
18. A. Chin, Y. Yang, L. Chai, R.W. Wong, and A.B. Rabie Effects of medicinal herb Salvia miltiorrhiza on osteoblastic cells in vitro Journal of Orthopaedic Research 29 2011 1059 1063
19. A.G. Costa, N.E. Cusano, B.C. Silva, S. Cremers, and J.P. Bilezikian Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis Nature Reviews Rheumatology 7 2011 447 456
20. L. Cui, T. Wu, Y.Y. Liu, Y.F. Deng, C.M. Al, and H.Q. Chen Tanshinone prevents cancellous bone loss induced by ovariectomy in rats Acta Pharmacology Sinica 25 2004 678 684
21. L. Cui, L.-Y. Zou, L. Y-Y, A. CM, T. Wu, and W. Y Preventing cancellous bone loss in steroid-treated rats and stimulating bone formation by water extract of Salvia miltiorrhixa and danshensu Chinese Pharmacological Bulletin 20 2004 286 291
22. L. Cui, Y.Y. Liu, T. Wu, C.M. Ai, and H.Q. Chen Osteogenic effects of D+beta-3,4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats Acta Pharmacology Sinica 30 2009 321 332
23. Y. Cui, B. Bhandary, A. Marahatta, G.H. Lee, B. Li, D.S. Kim, S.W. Chae, H.R. Kim, and H.J. Chae Characterization of Salvia miltiorrhiza ethanol extract as an anti-osteoporotic agent BMC Complementary Alternative Medicine 11 2011 120
24. L. Cui, T. Li, Y. Liu, L. Zhou, P. Li, B. Xu, L. Huang, Y. Chen, Y. Liu, X. Tian, W.S. Jee, and T. Wu Salvianolic acid B prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesis PLoS One 2012 7 ([Epub 2012 Apr 6])
25. H. Cui Characterization of glycosaminoglycan interaction sites and exosite inhibitors of cathepsin K. Craniofacial Science (M.Sc.Thesis) 2014 University of British Columbia Vancouver, BC, Canada
26. P. Damelio, and G.C. Isaia The use of raloxifene in osteoporosis treatment Expert Opinion on Pharmacotherapy 14 2013 949 956
27. F.H. Drake, R.A. Dodds, I.E. James, J.R. Connor, C. Debouck, S. Richardson, E. Lee-Rykaczewski, L. Coleman, D. Rieman, R. Barthlow, G. Hastings, and M. Gowen Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts Journal of Biological Chemistry 271 1996 12511 12516
28. P. Esbrit, and M.J. Alcaraz Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies Biochemical Pharmacology 85 2013 1417 1423
29. G.W. Fan, X.M. Gao, H. Wang, Y. Zhu, J. Zhang, L.M. Hu, Y.F. Su, L.Y. Kang, and B.L. Zhang The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS Journal of Steroid Biochemistry & Molecular Biology 113 2009 275 280
30. M. Fazil, S. Baboota, J.K. Sahni, Ameeduzzafar, and J. Ali Bisphosphonates: therapeutics potential and recent advances in drug delivery Drug Delivery 2014 ([Epub ahead of print])
31. J. Folwarczna, M. Zych, J. Burczyk, H. Trzeciak, and H.I. Trzeciak Effects of natural phenolic acids on the skeletal system of ovariectomized rats Planta Medica 75 2009 1567 1572
32. S. Fu, N. Du, and W. Shi [Biomechanical experimental study on effective fraction of radix Salviae miltiorrhizae on healing of bone fracture] Zhongguo Zhong Xi Yi Jie He Za Zhi 19 1999 106 107
33. Z. Gao, Y. Lu, Halmurat-Upur, J. Jing, and D. Xu Study of osteoporosis treatment principles used historically by ancient physicians in Chinese Medicine Chinese Journal of Integrative Medicine 19 2013 862 868
34. P. Garnero, O. Borel, I. Byrjalsen, M. Ferreras, F.H. Drake, M.S. McQueney, N.T. Foged, P.D. Delmas, and J.M. Delaisse The collagenolytic activity of cathepsin K is unique among mammalian proteinases Journal of Biological Chemistry 273 1998 32347 32352
35. Z. Gong Clinical research of modified Qinge pill on diabetic osteoporosis Journal of Emergency in TCM 21 2012 1391 1392
36. B. Guo, G. Li, H. Xiao, H. Sun, and Y. Li MRI diagnosis and clinical comorehensive treatment for transientoOsteoporosis of the hip joint Journal Practical Radiology 23 2007 215 217
37. N.A. Hamdy Targeting the RANK/RANKL/OPG signaling pathway: a novel approach in the management of osteoporosis Current Opinion on Investigative Drugs 8 2007 299 303
38. M.Z. Hu [Effect of radix salviae miltiorrhizae on the mitotic activity of osteoblast-like cells isolated from chicken embryo calvariae cultured in vitro] Zhonghua Wai Ke Za Zhi 31 1993 251 253
39. J. Hu, and C. Li Clinical observation of bushen jianpi treatment of primary osteoporosis Hubei Journal of TCM 34 2012 11 12
40. L. Huan, H. Tu, and Y. Luo Clinical study of therapy of nourishing kidney and strengthening bone in preventing and treating glucocorticoid-induced osteoporosis of nephrotic syndrome patients Journal of Guangzhou University of Traditional Chinese Medicine 30 2013 5 8
41. Y. Huang, L. Zhao, and A. Zhou Clinical study on the effect of Chinese medicine Gukang prescription on osteoporosis and osteoarthritis Chinese Journal of Ethnomedicine and Ethnopharmacy 9 2011 85 86
42. P.R. Jensen, T.L. Andersen, B.L. Pennypacker, Duong le, and T. Delaisse, J.M. The bone resorption inhibitors odanacatib and alendronate affect post-osteoclastic events differently in ovariectomized rabbits Calcified Tissue International 94 2014 212 222
43. B. Ji, X. Chen, Z. Xie, J. Lin, F. Gao, and Y. Yuan Clinical research of self-made kidney-tonifying and blood circulation- promoting Chinese Medicine in patients with diabetic osteoporosis Guide of China Medicine 10 2012 3 4
44. M. Jia, Y. Nie, D.P. Cao, Y.Y. Xue, J.S. Wang, L. Zhao, K. Rahman, Q.Y. Zhang, and L.P. Qin Potential antiosteoporotic agents from plants: a comprehensive review Evidence-Based Complementary and Alternative Medicine 2012 2012 ([Epub 2012 Dec 31])
45. Q. Jiu, C. Zhu, Q. Qu, and P. Wang Clinical observation of the effect of QiangGu decoction on kidney-deficiency induced osteoporosis in 56 patients Shanxi Journal of Traditional Chinese Medicine 27 2006 957 958
46. R. Josse, A. Khan, D. Ngui, and M. Shapiro Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis Current Medical Research and Opinion 29 2013 205 216
47. H.H. Kim, J.H. Kim, H.B. Kwak, H. Huang, S.H. Han, H. Ha, S.W. Lee, E.R. Woo, and Z.H. Lee Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge Biochemical Pharmacology 67 2004 1647 1656
48. H.K. Kim, E.R. Woo, H.W. Lee, H.R. Park, H.N. Kim, Y.K. Jung, J.Y. Choi, S.W. Chae, H.R. Kim, and H.J. Chae The correlation of Salvia miltiorrhiza extract-induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone Immunopharmacology & Immunotoxicology 30 2008 347 364
49. H.B. Kwak, D. Yang, H. Ha, J.H. Lee, H.N. Kim, E.R. Woo, S. Lee, H.H. Kim, and Z.H. Lee Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1 Experimental Molecular Medicine 38 2006 256 264
50. H.B. Kwak, H.M. Sun, H. Ha, H.N. Kim, J.H. Lee, H.H. Kim, H.I. Shin, and Z.H. Lee Tanshinone IIA suppresses inflammatory bone loss by inhibiting the synthesis of prostaglandin E2 in osteoblasts European Journal of Pharmacology 601 2008 30 37
51. I.S. Lay, J.H. Chiu, M.S. Shiao, W.Y. Lui, and C.W. Wu Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line Planta Medica 69 2003 26 32
52. I.S. Lay, C.C. Hsieh, J.H. Chiu, M.S. Shiao, W.Y. Lui, and C.W. Wu Salvianolic acid B enhances in vitro angiogenesis and improves skin flap survival in Sprague-Dawley rats Journal of Surgical Research 115 2003 279 285
53. S.Y. Lee, D.Y. Choi, and E.R. Woo Inhibition of osteoclast differentiation by tanshinones from the root of Salvia miltiorrhiza bunge Archives of Pharmaceutical Research 28 2005 909 913
54. S.U. Lee, S.J. Park, H.B. Kwak, J. Oh, Y.K. Min, and S.H. Kim Anabolic activity of ursolic acid in bone: stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo Pharmacological Research 58 2008 290 296
55. S.F. Lei, Y. Chen, D.H. Xiong, L.M. Li, and H.W. Deng Ethnic difference in osteoporosis-related phenotypes and its potential underlying genetic determination Journal of Musculoskeletal and Neuronal Interactions 6 2006 36 46
56. L. Li, Y. Zhou, X. Shao, Y. Liu, R. Wang, and D. Wang Keto-salvia preventing postmenopausal osteoporosis Chinese Journal of Osteoporosis 2 1996 78 81
57. H. Li, and F. Liu Clinical observation of ciyin Bushen Zhuanggu decoction treatment of post-menopausal osteoporosis China Journal of TCM (Zhongguo Zhongyiyao Zazhi) 2 2004 114 116
58. M.H. Li, J.M. Chen, Y. Peng, Q. Wu, and P.G. Xiao Investigation of Danshen and related medicinal plants in China Journal of Ethnopharmacology 120 2008 419 426
59. S. Li, Q. Li, and G. Luo Effect of ZhuangGu prescription plus Caltrate on 31 cases of diabetes induced osteoporosis Shanxi Journal of Traditional Chinese Medicine 29 2008 984 986
60. Z. Li, J. He, and Z. Zhao 30 case report on effect of Kang Bu Song capasule on post-menopausal osteoporosis Shanxi Journal of Traditional Chinese Medicine 29 2008 444
61. Y.G. Li, L. Song, M. Liu, Z.B. Hu, and Z.T. Wang Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen) Journal of Chromatography A 1216 2009 1941 1953
62. Z. Li, H. Tong, G. Sun, R. Lao, and Z. Liu The effect of Kanggusong soup plus Caltrate D on the alterations of serum ALP and IL-6 in postmenopausal osteoporosis Journal of Yunnan University of Traditional Chinese Medicine 34 2011 37 39
63. Z. Li, W. Zhang, R. Wei, and X. Zhang Treatment of postmenopausal osteoporosis with Kanggusong decoction combined with caltrate D: a report of 60 cases Journal of Traditional Chinese Medicine 52 2011 1237 1238
64. K. Lippuner The future of osteoporosis treatment - a research update Swiss Medical Weekly 142 2012 w13624
65. J. Liu Clinical observation of the effect of Xian Ling Gu Bao capsule on 86 cases of osteoporosis Zhejiang Journal of Integrated Traditional Chinese and Western Medicine 117 2007 702 703
66. Y.R. Liu, S.X. Qu, M.F. Maitz, R. Tan, and J. Weng The effect of the major components of Salvia Miltiorrhiza Bunge on bone marrow cells Journl of Ethnopharmacology 111 2007 573 583
67. W. Liu, M. Mai, Y. Liu, and G. Gao Treatment of postmenopausal osteoporosis with decoction of kidney- and spleen-strengthening and blood circulation-activating effects: a report of 33 cases Journal of Anhui TCM College 28 2009 33 34
68. Y. Liu, J.P. Liu, and Y. Xia Chinese herbal medicines for treating osteoporosis Cochrane Database of Systematic Reviews 3 2014 CD005467
69. P. Liu, P. Hu, R.X. Deng, R. Li, L. Yang, and W.P Yin Triterpenoids from the Flowers of Salvia miltiorrhiza Helvetica Chimica Acta 94 2011 136 141
70. Y. Lu, and L.Y. Foo Polyphenolics of salvia - a review Phytochemistry 59 2002 117 140
71. Q. Ma Effect of GuShuKang granule on 86 cases of osteoporosis Shanxi Journal of Traditional Chinese Medicine 25 2004 1096 1097
72. S.C. Manolagas, S. Kousteni, and R.L. Jilka Sex steroids and bone Recent Progress in Hormone Research 57 2002 385 409
73. M.J. Maricic Oral calcitonin Current Osteoporosis Reports 10 2012 80 85
74. B. Miao, J. Wang, Y. Zhu, C. Yue, and M. Chen [Experimental study on effect of Salvia miltiorrhiza on alveolar bone metabolism and variation in bone mass in diabetic rats] Zhongguo Zhong Yao Za Zhi 37 2012 1659 1662
75. Y. Mukudai, S. Kondo, T. Koyama, C. Li, S. Banka, A. Kogure, K. Yazawa, and S. Shintani Potential anti-osteoporotic effects of herbal extracts on osteoclasts, osteoblasts and chondrocytes in vitro BMC Complementary Alternative Medicine 14 2014 29
76. S. Nagase, M. Ohyama, Y. Hashimoto, M. Small, J. Sharpe, J. Manako, T. Kuwayama, and S. Deacon Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women Journal of Bone and Mineral Metabolism 2014 ([Epub ahead of print])
77. G.L. Nanninga, K. de Leur, M.J. Panneman, M. van der Elst, and K.A. Hartholt Increasing rates of pelvic fractures among older adults: the Netherlands, 1986-2011 Age Ageing 2014 ([Epub ahead of print])
78. V. Nicolin, F. Dal Piaz, S.L. Nori, P. Narducci, and N. De Tommasi Inhibition of bone resorption by Tanshinone VI isolated from Salvia miltiorrhiza Bunge European Journal of Histochemistry 54 2010 e21
79. C. Ohlsson Bone metabolism in 2012: novel osteoporosis targets Nature Reviews Endocrinology 9 2013 72 74
80. (Compiled by The State Pharmacopoeia Commission of the PR China) English Edition Pharmacopoeia of the Peoples Republic of China 2010 1 2010 China Medical Science Press Beijing
81. S. Rozenberg, J. Vandromme, and C. Antoine Postmenopausal hormone therapy: risks and benefits Nature Reviews Endocrinology 9 2013 216 227
82. T.M. Runger, S. Adami, C.L. Benhamou, E. Czerwinski, J. Farrerons, D.L. Kendler, L. Mindeholm, G. Realdi, C. Roux, and V. Smith Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib Journal of the American Acadamy of Dermatology 66 2012 e89 96
83. W. Shi, S. Fu, and N. Du [Effect of effective fraction of Radix Salviae miltiorrhizae on procollagen gene expression in fracture healing] Zhongguo Zhong Xi Yi Jie He Za Zhi 20 2000 269 271
84. C. Shi, W. Jia, and X. Yang 54 case report on effect of Kang Shu Jian Gu Granule on primary osteoporosis Shanxi Journal of Traditional Chinese Medicine 26 2005 63 764
85. C. Shi, P. Yuan, and X. Yang Observation of granule of Kang-shu Jian-gu on postmenopausal osteoporosis: a report of 40 cases Shanxi Journal of Traditional Chinese Medicine 8 2012 16 17
86. N.A. Sims, and N.C. Walsh Intercellular cross-talk among bone cells: new factors and pathways Current Osteoporosis Reports 10 2012 109 117
87. N.A. Sims, and K.W. Ng Implications of osteoblast-osteoclast interactions in the management of osteoporosis by antiresorptive agents denosumab and odanacatib Current Osteoporosis Reports 12 2014 98 106
88. H. Song The applications of tonifying kidney and benefiting essence in 84 patients with osteoporosis Shanxi Journal of Traditional Chinese Medicine 24 2003 1075 1077
89. K. Steinkamp-Fenske, L. Bollinger, N. Voller, H. Xu, Y. Yao, R. Bauer, U. Forstermann, and H. Li Ursolic acid from the Chinese herb danshen (Salvia miltiorrhiza L.) upregulates eNOS and downregulates Nox4 expression in human endothelial cells Atherosclerosis 195 2007 e104 111
90. C. Su, T. Han, J. Chen, T. Li, Q. Ming, S. Chen, and L. Qin Isolation and identifciation of endophytic fungi from Salvia miltiorrhiza Bge. Screening of anti-platelet aggregation active strains Pharmaceutical Care and Research 13 2013 191 194
91. R. Tamma, and A. Zallone Osteoblast and osteoclast crosstalks: from OAF to Ephrin Inflammaion & Allergy-Drug Targets 11 2012 196 200
92. C. Tang Clinical observations on the effect of tonifying kidney and strengthening bone and improving blood circulation prescription on primary osteoporosis in 42 cases Guiding Journal of Traditional Chinese Medicine and Pharmacy 18 2012 50 51
93. S.L. Teitelbaum Bone resorption by osteoclasts Science 289 2000 1504 1508
94. K. Vaananen Mechanism of osteoclast mediated bone resorption - rationale for the design of new therapeutics Advances in Drug Delivery Reviews 57 2005 959 971
95. S. Verma, J.H. Rajaratnam, J. Denton, J.A. Hoyland, and R.J. Byers Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis Journal of Clinical Pathology 55 2002 693 698
96. L. Wan, and Q. Liu 24 case report on effect of Shi Wei Gu Kang Kou Fu Ye on post-manopausal osteoporosis Liaoning Journal of Traditional Chinese Medicine 36 2009 1923 1924
97. W. Wang, S. Guo, and Y. Jiang Clinical research on the treatment of 80 cases of primary osteoporosis with tonifying kidney and activating blood decoction Guiding Journal of Traditional Chinese Medicine 11 2005 59 61
98. H. Wang, J. Ge, G. Shi, W. Zhao, and W. Tian Clinical study on the effect of Gushukang capsule in primary osteoporosis treatment Chinese Journal of Traditional Medicine Trauma & Orthopaedy 14 2006 11 16
99. X. Wang, Y. Lin, and C. Wen 50 case clinical observation on effect of Qi Huo Dan Jian Gu prescription on post-menopausal osteoporosis New Journal of TCM 38 2006 22 23
100. X. Wang, S.L. Morris-Natschke, and K.H. Lee New developments in the chemistry and biology of the bioactive constituents of Tanshen Medicinal Research Reviews 27 2007 133 148
101. Y. Wang, and H. Wang Contrast study on the effect of Jiangu capasule on primary osteoporosis Chinese Journal of GuangMing Chinese Medicine 23 2008 1125 1126
102. Y. Wang, X.X. Wang, L.N. Zhang, S.M. Jin, and J. Zhang Effects of traditional Chinese medicine on bone remodeling during orthodontic tooth movement Journal of Ethnopharmacology 141 2012 642 646
103. Wang, Z.Q., Li, J.L., Sun, Y.L., Yao, M., Gao, J., Yang, Z., Shi, Q., Cui, X.J., Wang,Y.J., 2013. Chinese herbal medicine for osteoporosis: a systematic review of randomized controlled trails. Evidence-Based Complementary & Alternative Medicine 2013, 356260
104. M. Wei, and X. Wang Clinical study on the effect of Yi Tu Jiang Tang Ye on type 2 diabetes indueced osteoporosis China Journal of Traditional Chinese Medicine and Pharmacy 11 1996 51
105. R. Wei, R. Lao, Z. Liu, G. Xu, and Z. Li Effect of anti-osteoporosis capsule on ostealgia and bone metabolismof postmenopausal osteoporosis patients Journal of New Chinese Medicine 43 2011 61 63
106. J. Wijkmans, and J. Gossen Inhibitors of cathepsin K: a patent review (2004-2010) Expert Opinion on Therapeutic Patents 21 2011 1611 1629
107. D.S. Williams, P.J. McCracken, M. Purcell, M. Pickarski, P.D. Mathers, A.T. Savitz, J. Szumiloski, R.Y. Jayakar, S. Somayajula, S. Krause, K. Brown, C.T. Winkelmann, B.B. Scott, L. Cook, S.L. Motzel, R. Hargreaves, J.L. Evelhoch, A. Cabal, B.J. Dardzinski, T.N. Hangartner, and Duong le, T. Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate Bone 56 2013 489 496
108. S. Wilson, S. Hashamiyan, L. Clarke, P. Saftig, J. Mort, V.M. Dejica, and D. Bromme Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities American Journal of Pathology 175 2009 2053 2062
109. R.W. Wong, and A.B. Rabie Effect of Danshen extract on bone formation Annals of the Royal Australasian College of Dental Surgery 19 2008 171 174
110. Y. Wu The effect of Jian Gu San on 76 post-menopausal osteoporosis Information on Traditional Chinese medicine 19 2002 60
111. M. Wu, E. Li, S. Zhao, X. Bai, and A. Li Channel tropism of the prescription for kidney tonifying by target-oriented administration for osteoporosis Journal of Clinical Rehabilitative Tissue Engineering Research 11 2007 5336 5340
112. 2+-nuclear factor of activated T-cells cytoplasmic 1 signaling pathways Journal of Bone and Mineral Research 27 2012 1298 1308
113. Y.B. Wu, Z.Y. Ni, Q.W. Shi, M. Dong, H. Kiyota, Y.C. Gu, and B. Cong Constituents from Salvia species and their biological activities Chemical Reviews 112 2012 5967 6026
114. L. Xia, J. Kilb, H. Wex, A. Lipyansky, V. Breuil, L. Stein, J.T. Palmer, D.W. Dempster, and D. Bromme Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption cathepsin K-activity by peptidyl vinyl sulfones Biological Chemistry 380 1999 679 687
115. B. Xu, L. Cui, W. Chen, T. Wei, and T. Wu [Effects of DanShenGuBao on biomechanical properties and bone mineral density of femur induced by retinoic acid in rats] Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 27 2010 307 310
116. D. Xu, L. Xu, C. Zhou, W.Y. Lee, T. Wu, L. Cui, and G. Li Salvianolic acid B promotes osteogenesis of human mesenchymal stem cells through activating ERK signaling pathway International Journal of Biochemistry & Cell Biology 51 2014 1 9
117. D.S. Yamashita, and R.A. Dodds Cathepsin K and the design of inhibitors of cathepsin K Current Pharmaceutical Design 6 2000 1 24
118. Y. Yang, A. Chin, L. Zhang, J. Lu, and R.W. Wong The role of traditional Chinese medicines in osteogenesis and angiogenesis Phytotherapy Research 28 2014 1 8
119. M. Zeng, L. Pan, S. Qi, Y. Cao, H. Zhu, L. Guo, and J. Zhou Systematic review of recent advances in pharmacokinetics of four classical Chinese medicines used for the treatment of cerebrovascular disease Fitoterapia 88C 2013 50 75
120. W. Zhang 45 clinical reports on treating senile osteoporosis by invigorating spleen and improving kidney and blood stasis Gansu Journal of Traditional Chinese Medicine 18 2005 22
121. Y. Zhang, W. Yu, and X. Wang Effects of Tanggukang on serum free radical metabolism in patients with diabetic osteoporosis Journal of Clinical Rehabilitative Tissue Engineering Research 12 2008 1251 1254
122. Z. Zhang, T. You, L. Zou, T. Wu, Y. Wu, and L. Cui Effect of Danshen root compound on blood lipid and bone biomechanics in mice with hyperlipemia-induced osteoporosis Journal of Southern Medical University 37 2008 1550 1553
123. Y. Zhang, P. Jiang, M. Ye, S.H. Kim, C. Jiang, and J. Lu Tanshinones: sources, pharmacokinetics and anti-cancer activities International Journal of Molecuar Sciences 13 2012 13621 13666
124. Y. Zhao, Y. Huai, J. Jin, M. Geng, and J.X. Li Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss Menopause 18 2011 690 697
125. X. Zhao, Y. Feng, and Y. Peng Prevention and treatment of osteoporosis with Chinese Herbal Medicines Chinese Herbal Medicines 4 2012 265 270
126. Y. Zheng, X. Li, and Y. Shi The clinical observation of the osteoporosis in aged persons treated by kidney-invigorating and bone-strengthening decoction Chinese Journal of Osteoporosis 13 2007 571 572
127. L. Zhou, Z. Zuo, and M.S. Chow Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use Journal Clinical Pharmacology 45 2005 1345 1359
128. X. Zhou, K. Chan, and J.H. Yeung Herb-drug interactions with Danshen (Salvia miltiorrhiza): a review on the role of cytochrome P450 enzymes Drug Metabolism and Drug Interactions 27 2012 9 18
129. H. Zhu, Z. Duan, K. Liao, N. Tan, and S. Huang Clinical observations on the effect of tonifying kidney and benefiting essence and improving blood circulation on liver and kidney deficiency induced primary osteoporosis Guiding Journal of Traditional Chinese Medicine and Pharmacy 17 2011 30 32